Ezgi Yaja
Vice President of Investor Relations
Replay available
Inspire Medical Systems, Inc. (NYSE: INSP) Q1 2025 earnings conference call, held 2025-05-05. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations
Chairman and Chief Executive Officer
Chief Financial Officer
Analyst at Bank of America Securities
Analyst at UBS
Analyst at JPMorgan
Analyst at Piper Sandler
Analyst at Truist
Analyst at Morgan Stanley
Analyst at Baird
Analyst at Nefron Research
Analyst at Wells Fargo
Analyst at Mizuho Financial Group
Analyst at CIFL
Analyst at KeyBank Capital Markets
Analyst at Wolf Research
Analyst at Layering Partners
Good afternoon. My name is Dilem, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Inspire Medical Systems first quarter 2025 conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I will now hand the call over to your first speaker, Ezgi Yaja, the Vice President of Investor Relations at Inspire. You may begin the conference. Thank you, Dilem, and thank you all for participating in today's call. Joining me are Tim Herbert, Chairman and Chief Executive Officer, and Rick Buholz, Chief Financial Officer. Earlier today, we released financial results for the three months ended March 31, 2025. A copy of the press release is available on our website. On this call, management will make forward-looking statements within the meaning of the federal securities laws. All forward-looking statements, including, without limitation, those relating to our operations, financial results, and financial condition, investments in our business, full-year 2025 financial and operational outlook, and changes in market access are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ. Accordingly, you should not place undue reliance on these statements. Please see our filings with the Securities and Exchange Commission, including our Form 10-Q which we file...